The carnitine system: a new therapeutical approach to cardiovascular diseases
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Dordrecht u.a.
Kluwer
1995
|
Schriftenreihe: | Developments in cardiovascular medicine
162 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XII, 393 S. graph. Darst. |
ISBN: | 0792333187 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV010337973 | ||
003 | DE-604 | ||
005 | 20060728 | ||
007 | t | ||
008 | 950811s1995 d||| |||| 00||| eng d | ||
020 | |a 0792333187 |9 0-7923-3318-7 | ||
035 | |a (OCoLC)31707430 | ||
035 | |a (DE-599)BVBBV010337973 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-12 | ||
050 | 0 | |a RC684.C37 | |
082 | 0 | |a 616.1/061 |2 20 | |
084 | |a YB 8700 |0 (DE-625)153168:12905 |2 rvk | ||
245 | 1 | 0 | |a The carnitine system |b a new therapeutical approach to cardiovascular diseases |c ed. by J. W. de Jong ... |
264 | 1 | |a Dordrecht u.a. |b Kluwer |c 1995 | |
300 | |a XII, 393 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Developments in cardiovascular medicine |v 162 | |
650 | 7 | |a Carnitine |2 gtt | |
650 | 7 | |a Hart- en vaatziekten |2 gtt | |
650 | 7 | |a Hartinfarct |2 gtt | |
650 | 7 | |a Ischemie |2 gtt | |
650 | 4 | |a Acetylcarnitine |x Therapeutic use | |
650 | 4 | |a Cardiovascular Diseases |x drug therapy | |
650 | 4 | |a Cardiovascular system |x Diseases |x Chemotherapy | |
650 | 4 | |a Carnitine |x Derivatives |x Therapeutic use | |
650 | 4 | |a Carnitine |x Therapeutic use | |
650 | 4 | |a Carnitine |x therapeutic use | |
650 | 4 | |a Heart |x drug effects | |
650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Carnitin |0 (DE-588)4129182-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Kardiovaskuläre Krankheit |0 (DE-588)4024666-8 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Carnitin |0 (DE-588)4129182-7 |D s |
689 | 0 | 1 | |a Kardiovaskuläre Krankheit |0 (DE-588)4024666-8 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Kardiovaskuläre Krankheit |0 (DE-588)4024666-8 |D s |
689 | 1 | 1 | |a Carnitin |0 (DE-588)4129182-7 |D s |
689 | 1 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Carnitin |0 (DE-588)4129182-7 |D s |
689 | 2 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Jong, Jan Willem de |d 1942- |e Sonstige |0 (DE-588)131920472 |4 oth | |
830 | 0 | |a Developments in cardiovascular medicine |v 162 |w (DE-604)BV000000660 |9 162 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006880669&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-006880669 |
Datensatz im Suchindex
_version_ | 1804124759190929408 |
---|---|
adam_text | LSI- THE CARNITINE SYSTEM A NEW THERAPEUTICAL APPROACH TO CARDIOVASCULAR
DISEASES EDITED BY J.W. DE JONG THORAXCENTER, ERASMUS UNIVERSITY,
ROTTERDAM, THE NETHERLANDS AND R. FERRARI CATTEDRA DI CARDIOLOGIA,
UNIVERSITA DEGLI STUDI DI BRESCIA, FONDAZIONE CLINICA DEL LAVORO DI
PAVIA, GUSSAGO I BRESCIA, ITALY KLUWER ACADEMIC PUBLISHERS DORDRECHT /
BOSTON / LONDON TABLE OF CONTENTS LIST OF CONTRIBUTORS IX 1.
INTRODUCTION 1 ROBERTO FERRARI AND JAN WILLEM DE JONG PART ONE: THE
CARNITINE SYSTEM IN THE HEART: MOLECULAR ASPECTS 2. CARNITINE-DEPENDENT
PATHWAYS IN HEART MUSCLE 7 JON BREMER 3. CARNITINE AND CARNITINE ESTERS
IN MITOCHONDRIAL METABOLISM AND FUNCTION 21 FABIO DI LISA, ROBERTA
BARBATO, ROBERTA MENABO AND NORIS SILIPRANDI 4. THE EFFECTS OF CARNITINE
ON MYOCARDIAL CARBOHYDRATE METABOLISM 39 BRETT O. SCHONEKESS AND GARY D.
LOPASCHUK 5. ACCUMULATION OF FATTY ACIDS AND THEIR CARNITINE DERIVATIVES
DURING MYOCARDIAL ISCHEMIA 53 GER J. VAN DER VUSSE 6. CARNITINE
ACYLCARNITINE TRANSLOCASE IN ISCHEMIA 69 JEANIE B. MCMILLIN 7.
AMPHIPHILIC INTERACTIONS OF LONG-CHAIN FATTY ACYLCARNITINES WITH
MEMBRANES: POTENTIAL INVOLVEMENT IN ISCHEMIC INJURY 83 JOS M.J. LAMERS
VI TABLE OF CONTENTS 8. MITOCHONDRIAL INJURY IN THE
ISCHEMIC-REOXYGENATED CARDIOMYOCYTE: THE ROLE OF LIPIDS AND OTHER
PATHOGENIC FACTORS 101 HANS MICHAEL PIPER, THOMAS NOLL AND BERTHOLD
SIEGMUND 9. FREE RADICAL-MEDIATED DAMAGE AND CARNITINE ESTERS 123 JOHAN
FOKKE KOSTER 10. CARNITINE TRANSPORT IN VOLUME-OVERLOADED RAT HEARTS 133
JOSEF MORAVEC, ZAINAB EL ALAOUI-TABLIBI AND CHRISTIAN BRUNOLD 11.
MYOCARDIAL CARNITINE DEFICIENCY IN HUMAN CARDIOMYOPATHY 145 VERA
REGITZ-ZAGROSEK AND ECKART FLECK PART TWO: THERAPEUTIC EFFICACY OF
L-CARNITINE AT THE MYOCARDIAL LEVEL 12. IS THE CARNITINE SYSTEM PART OF
THE HEART ANTIOXIDANT NETWORK? ARDUINO ARDUINI, SECONDO DOTTORI,
FRANCESCO MOLAJONI, RUTH 169 KIRK AND EDOARDO ARRIGONI-MARTELLI 13.
EXPERIMENTAL EVIDENCE OF THE ANTI-ISCHEMIC EFFECT OF L-CARNITINE 183
DENNIS J. PAULSON AND AUSTIN L. SHUG 14. CARNITINE METABOLISM DURING
DIABETES AND HYPERTHYROIDY 199 DANIELLE FEUVRAY 15. CARNITINE AND
LACTATE METABOLISM 209 ROBERTO FERRARI AND ODOARDO VISIOLI 16.
THERAPEUTIC POTENTIAL OF L-CARNITINE IN PATIENTS WITH ANGINA PECTORIS
225 CARL J. PEPINE AND MICHAEL A. WELSCH 17. CARNITINE AND MYOCARDIAL
INFARCTION 245 PAOLO RIZZON, MATTEO DI BIASE, GIUSEPPINA BIASCO AND
MARIA VITTORIA PITZALIS PART THREE: THERAPEUTIC EFFICACY OF
PROPIONYL-L-CARNITINE 18. CARDIAC ELECTROPHYSIOLOGY OF
PROPIONYL-L-CARNITINE 253 ALESSANDRO MUGELLI, ELISABETTA CERBAI AND
MARIO BARBIERI TABLE OF CONTENTS VII 19. ACUTE VS. CHRONIC TREATMENT
WITH PROPIONYL-L-CARNITIHE: BIOCHEMICAL, HEMODYNAMIC AND
ELECTROPHYSIOLOGICAL EFFECTS ON RABBIT HEART 261 JAN WILLEM DE JONG,
ALESSANDRO MUGELLI, FABIO DI LISA AND ROBERTO FERRARI 20. MECHANICAL
RECOVERY WITH PROPIONYL-L-CARNITINE 275 A. JAMES LIEDTKE 21.
DISSOCIATION OF HEMODYNAMIC AND METABOLIC EFFECTS OF
PROPIONYL-L-CARNITINE IN ISCHEMIC PIG HEART 291 PIETER D. VERDOUW, LOES
M.A. SASSEN, DIRK J. DUNCKER AND JOS M.J. LAMERS 22. EFFECT OF
PROPIONYL-L-CARNITINE ON RATS WITH EXPERIMENTALLY INDUCED
CARDIOMYOPATHIES 307 ROSELLA MICHELETTI, ANTONIO SCHIAVONE AND GIUSEPPE
BIANCHI 23. UTILIZATION OF PROPIONYL-L-CARNITINE FOR THE TREATMENT OF
HEART FAILURE 323 ROBERTO FERRARI AND INDER ANAND 24. HEMODYNAMIC AND
METABOLIC EFFECT OF PROPIONYL-L-CARNITINE IN PATIENTS WITH HEART FAILURE
337 SALVATORE CAPONNETTO AND CLAUDIO BRUNELLI 25. CARNITINE METABOLISM
IN PERIPHERAL ARTERIAL DISEASE 353 WILLIAM R. HIATT AND ERIC P. BRASS
26. EFFECT OF PROPIONYL-L-CARNITINE ON EXPERIMENTAL MODELS OF PERIPHERAL
ARTERIOPATHY IN THE RAT 365 NERINA CORSICO AND EDOARDO ARRIGONI-MARTELLI
27. EFFECT OF L-CARNITINE AND PROPIONYL-L-CARNITINE ON CARDIOVASCULAR
DISEASES: A SUMMARY 383 JAN WILLEM DE JONG AND ROBERTO FERRARI
|
any_adam_object | 1 |
author_GND | (DE-588)131920472 |
building | Verbundindex |
bvnumber | BV010337973 |
callnumber-first | R - Medicine |
callnumber-label | RC684 |
callnumber-raw | RC684.C37 |
callnumber-search | RC684.C37 |
callnumber-sort | RC 3684 C37 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | YB 8700 |
ctrlnum | (OCoLC)31707430 (DE-599)BVBBV010337973 |
dewey-full | 616.1/061 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.1/061 |
dewey-search | 616.1/061 |
dewey-sort | 3616.1 261 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02554nam a2200637 cb4500</leader><controlfield tag="001">BV010337973</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20060728 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">950811s1995 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0792333187</subfield><subfield code="9">0-7923-3318-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)31707430</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010337973</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC684.C37</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YB 8700</subfield><subfield code="0">(DE-625)153168:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The carnitine system</subfield><subfield code="b">a new therapeutical approach to cardiovascular diseases</subfield><subfield code="c">ed. by J. W. de Jong ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht u.a.</subfield><subfield code="b">Kluwer</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 393 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in cardiovascular medicine</subfield><subfield code="v">162</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Carnitine</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hart- en vaatziekten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hartinfarct</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ischemie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acetylcarnitine</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular system</subfield><subfield code="x">Diseases</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carnitine</subfield><subfield code="x">Derivatives</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carnitine</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carnitine</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart</subfield><subfield code="x">drug effects</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Carnitin</subfield><subfield code="0">(DE-588)4129182-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kardiovaskuläre Krankheit</subfield><subfield code="0">(DE-588)4024666-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Carnitin</subfield><subfield code="0">(DE-588)4129182-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Kardiovaskuläre Krankheit</subfield><subfield code="0">(DE-588)4024666-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Kardiovaskuläre Krankheit</subfield><subfield code="0">(DE-588)4024666-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Carnitin</subfield><subfield code="0">(DE-588)4129182-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Carnitin</subfield><subfield code="0">(DE-588)4129182-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jong, Jan Willem de</subfield><subfield code="d">1942-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)131920472</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in cardiovascular medicine</subfield><subfield code="v">162</subfield><subfield code="w">(DE-604)BV000000660</subfield><subfield code="9">162</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006880669&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006880669</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV010337973 |
illustrated | Illustrated |
indexdate | 2024-07-09T17:50:46Z |
institution | BVB |
isbn | 0792333187 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006880669 |
oclc_num | 31707430 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-12 |
owner_facet | DE-355 DE-BY-UBR DE-12 |
physical | XII, 393 S. graph. Darst. |
publishDate | 1995 |
publishDateSearch | 1995 |
publishDateSort | 1995 |
publisher | Kluwer |
record_format | marc |
series | Developments in cardiovascular medicine |
series2 | Developments in cardiovascular medicine |
spelling | The carnitine system a new therapeutical approach to cardiovascular diseases ed. by J. W. de Jong ... Dordrecht u.a. Kluwer 1995 XII, 393 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Developments in cardiovascular medicine 162 Carnitine gtt Hart- en vaatziekten gtt Hartinfarct gtt Ischemie gtt Acetylcarnitine Therapeutic use Cardiovascular Diseases drug therapy Cardiovascular system Diseases Chemotherapy Carnitine Derivatives Therapeutic use Carnitine Therapeutic use Carnitine therapeutic use Heart drug effects Pharmakologie (DE-588)4045687-0 gnd rswk-swf Carnitin (DE-588)4129182-7 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Kardiovaskuläre Krankheit (DE-588)4024666-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Carnitin (DE-588)4129182-7 s Kardiovaskuläre Krankheit (DE-588)4024666-8 s DE-604 Pharmakotherapie (DE-588)4076066-2 s Pharmakologie (DE-588)4045687-0 s Jong, Jan Willem de 1942- Sonstige (DE-588)131920472 oth Developments in cardiovascular medicine 162 (DE-604)BV000000660 162 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006880669&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | The carnitine system a new therapeutical approach to cardiovascular diseases Developments in cardiovascular medicine Carnitine gtt Hart- en vaatziekten gtt Hartinfarct gtt Ischemie gtt Acetylcarnitine Therapeutic use Cardiovascular Diseases drug therapy Cardiovascular system Diseases Chemotherapy Carnitine Derivatives Therapeutic use Carnitine Therapeutic use Carnitine therapeutic use Heart drug effects Pharmakologie (DE-588)4045687-0 gnd Carnitin (DE-588)4129182-7 gnd Pharmakotherapie (DE-588)4076066-2 gnd Kardiovaskuläre Krankheit (DE-588)4024666-8 gnd |
subject_GND | (DE-588)4045687-0 (DE-588)4129182-7 (DE-588)4076066-2 (DE-588)4024666-8 (DE-588)4143413-4 |
title | The carnitine system a new therapeutical approach to cardiovascular diseases |
title_auth | The carnitine system a new therapeutical approach to cardiovascular diseases |
title_exact_search | The carnitine system a new therapeutical approach to cardiovascular diseases |
title_full | The carnitine system a new therapeutical approach to cardiovascular diseases ed. by J. W. de Jong ... |
title_fullStr | The carnitine system a new therapeutical approach to cardiovascular diseases ed. by J. W. de Jong ... |
title_full_unstemmed | The carnitine system a new therapeutical approach to cardiovascular diseases ed. by J. W. de Jong ... |
title_short | The carnitine system |
title_sort | the carnitine system a new therapeutical approach to cardiovascular diseases |
title_sub | a new therapeutical approach to cardiovascular diseases |
topic | Carnitine gtt Hart- en vaatziekten gtt Hartinfarct gtt Ischemie gtt Acetylcarnitine Therapeutic use Cardiovascular Diseases drug therapy Cardiovascular system Diseases Chemotherapy Carnitine Derivatives Therapeutic use Carnitine Therapeutic use Carnitine therapeutic use Heart drug effects Pharmakologie (DE-588)4045687-0 gnd Carnitin (DE-588)4129182-7 gnd Pharmakotherapie (DE-588)4076066-2 gnd Kardiovaskuläre Krankheit (DE-588)4024666-8 gnd |
topic_facet | Carnitine Hart- en vaatziekten Hartinfarct Ischemie Acetylcarnitine Therapeutic use Cardiovascular Diseases drug therapy Cardiovascular system Diseases Chemotherapy Carnitine Derivatives Therapeutic use Carnitine Therapeutic use Carnitine therapeutic use Heart drug effects Pharmakologie Carnitin Pharmakotherapie Kardiovaskuläre Krankheit Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006880669&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV000000660 |
work_keys_str_mv | AT jongjanwillemde thecarnitinesystemanewtherapeuticalapproachtocardiovasculardiseases |